2021
Patterns of Care for Older Patients With Myelofibrosis: A Population-based Study
Meckstroth S, Wang R, Ma X, Podoltsev N. Patterns of Care for Older Patients With Myelofibrosis: A Population-based Study. Clinical Lymphoma Myeloma & Leukemia 2021, 21: e551-e558. PMID: 33648884, DOI: 10.1016/j.clml.2021.01.025.Peer-Reviewed Original ResearchConceptsPatterns of careOlder patientsEnd Results-Medicare databaseJAK inhibitor eraHigh-risk patientsPopulation-based studyUse of ruxolitinibJAK inhibitor ruxolitinibUnited States FoodRuxolitinib approvalMedian ageMedian timeTreatment patternsD claimsCurrent treatmentInhibitor ruxolitinibPatientsBetter outcomesClinical experienceDrug AdministrationMedicare Part BMyelofibrosisRuxolitinibStates FoodNew drugs
2012
New health conditions identified at a regional childhood cancer survivor clinic visit
Hogan M, Ma X, Kadan‐Lottick N. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatric Blood & Cancer 2012, 60: 682-687. PMID: 23023769, DOI: 10.1002/pbc.24360.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAmbulatory Care FacilitiesChildChild, PreschoolDelivery of Health CareFemaleHumansInfantInfant, NewbornMaleMass ScreeningNeoplasmsSurvivorsYoung AdultConceptsNew health conditionsClinic visitsSurvivorship clinicChildhood cancerHealth conditionsOdds ratioChildren's Oncology Group Long-Term FollowCancer treatment exposuresRegular medical careCancer diagnosisPotential treatment-related effectsLong-term followCancer survivorship clinicTherapy-related effectsTreatment-related effectsRisk-based screeningGroup of survivorsSurvivor clinicChest irradiationPulmonary dysfunctionSubsequent cancerLate complicationsNeurologic impairmentAssociated FactorsMultivariate regression model